TCTAP 2024 is underway in Incheon, Korea and our team is excited to be there and connect with you at our booth P12. Come visit and let's discuss how to Simplify the Complex with OrbusNeich.
#cardiotwitter #TCTAP2024 summitmd_cvrf

We are delighted to announce our TricValve clinical trial in China, a major leap in minimally invasive heart valve treatments. Led by Prof. Ge Junbo, this trial underscores our growth in the transcatheter valve market. More here: buff.ly/4aZyGKe

We are looking forward to the upcoming TCTAP 2024 in Korea and to welcoming you to our Booth No. P12 – come by and learn more about our ‘Simplify the Complex’ product portfolio. #cardiotwitter

Sapphire® NC24: Robustness without compromising crossability. Its true non-compliance minimizes dog-boning against resilient lesions. The optimal tool in daily practice with its most competitive entry and crossing profile across a broad range of sizes. buff.ly/2XKPC6L

Scoreflex® NC tackles complex lesions with focused force for effective plaque modification. Its low crossing profile, non-compliant safety & a diameter range of 1.75-4.0 mm (qtr sizes available) make this the perfect solution for precision & versatility. buff.ly/3HLdED6

The JADE® PTA balloon catheter series: an over-the-wire platform built on strength & non-compliant precision without compromising deliverability. Experience consistent uniform pressure distribution (minimizing dog-bone effect) & compatibility with 014, 018, and 035 guidewires.

This World Health Day, OrbusNeich champions everyone's right to quality healthcare, clean air & water, and safe living. Together, let's make these rights a reality. #MyHealthMyRight #WorldHealthDay

Our team is excited to connect with you at the 90. @DGKorg-Jahrestagung in Mannheim, Germany. Visit us at booth no. 219 to learn more about our product portfolio. #cardiotwitter

Sapphire® 3 is designed to perform under the most extreme conditions with its best-in-class crossability and re-crossability. Facilitating the smoothest lesion entry makes this the ultimate choice for your CTO toolbox.
buff.ly/3sD1nHX

Simplify the Complex with OrbusNeich at the 90. Jahrestagung Deutsche Gesellschaft für Kardiologie in Mannheim, Germany. Come visit us at Booth No. 219 and learn how our innovative devices can help to make a difference in your daily practice. #cardiotwitter

Last week, OrbusNeich's INSPIRE 2024 buzzed with energy. A big thank you to everyone involved in making it a celebration of growth & collaboration. Insightful talks, team activities & presentations enhanced our skills & connections. Here's to exceeding our potential together!

Teleport® Microcatheter: ultimate control & guidewire support in the most complex lesions. Exceptional tip durability & hybrid coil construction provide an optimal balance of trackability, maneuverability, kink resistance & flexibility from hub to tip. buff.ly/3sLcmz2

Many thanks to Dr. Mohamed Ayoub for his excellent proctorship at the recent CTO workshop. Utilizing our ‘Simplify the Complex’ CTO portfolio, he and his team provided a valuable learning experience for all attendees at University Heartcenter Bad Oeynhausen. #cardiotwitter

Sapphire® NC24: Robustness without compromising crossability. Its true non-compliance minimizes dog-boning against resilient lesions. The optimal tool in daily practice with its most competitive entry and crossing profile across a broad range of sizes. buff.ly/2XKPC6L

We are looking forward to the upcoming HKSTENT-CICF 2024 in Hong Kong and to welcoming you to our Booth No. 20 – come by and learn more about our ‘Simplify the Complex’ product portfolio. #cardiotwitter #OrbusNeich

Join us at Singapore Valve for a Lunch Symposium on TricValve® Bicaval Valves System, addressing unmet needs in functional TR with expert insights. Visit Booth No. 1 for more on our innovations. #cardiotwitter

This International Women’s Day, we celebrate the talented women at OrbusNeich & globally. Emphasizing unity & inclusion, we're dedicated to valuing all contributions & recognizing every woman's potential. #IWD2024 #InspireInclusion

2023 annual results: Record revenue ($1543.9M, +12.5%) & profit ($45.1M, +143.8%). Gross profit up 15.2% to $106.5M. Dividend proposed: HK10¢/share. Added 4 CE products via M&A & expanded globally. Over 240 patents & major R&D expansion underway. More: buff.ly/3vaEj8Z

JADE® PTA Balloon Catheter: OTW platform built on strength & non-compliant precision without compromising deliverability. Experience consistent uniform pressure distribution (minimizing dog-bone effect) & compatibility with 014, 018 & 035 guidewires. buff.ly/3T2xgr5

Join us at CLI-C Global to explore cutting-edge CLTI treatment strategies. Proudly sponsoring Prof. Tze Tec Chong's presentation on March 8. Don't miss out! Visit Booth No. 2 to connect with our team and discover our innovative solutions.